Human medicines European public assessment report (EPAR): Bexsero, meningococcal group B Vaccine (rDNA, component, adsorbed), Date of authorisation: 13/01/2013, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Bexsero, meningococcal group B Vaccine (rDNA, component, adsorbed), Date of authorisation: 13/01/2013, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Enjaymo, sutimlimab, Date of authorisation: 15/11/2022, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Enjaymo, sutimlimab, Date of authorisation: 15/11/2022, Revision: 8, Status: Authorised

Training session on human variations web-based electronic application form (eAF) for CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 15 September 2025, 10:00 (CEST) to 15 September 2025, 11:30 (CEST)

Training session on human variations web-based electronic application form (eAF) for CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 15 September 2025, 10:00 (CEST) to 15 September 2025, 11:30 (CEST)

Q&A clinic on web-based application form functionalities for CAPs and non-CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, from 9 October 2025, 11:00 (CEST) to 9 October 2025, 12:00 (CEST)

Q&A clinic on web-based application form functionalities for CAPs and non-CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, from 9 October 2025, 11:00 (CEST) to 9 October 2025, 12:00 (CEST)

Q&A clinic on web-based electronic application form (eAF) functionalities for CAPs and non-CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 September 2025, 10:00 (CEST) to 30 September 2025, 11:00 (CEST)

Q&A clinic on web-based electronic application form (eAF) functionalities for CAPs and non-CAPs, Online, European Medicines Agency, Amsterdam, the Netherlands, from 30 September 2025, 10:00 (CEST) to 30 September 2025, 11:00 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness